Health · 1 views
New recommendations address GLP-1 medications across women's reproductive years
As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have…
AI Summary
As the use of GLP-1 and other incretin-based medications for obesity continues to grow worldwide, researchers at Marshall University have contributed to an international effort to address one of medicine's most pressing unanswered questions: How should these medications be used by women before, during and after pregnancy?
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedEnjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage